Lotus Eye Hospital and Institute Share Price

Lotus Eye Hospital and Institute Share Price

  • 124.21-3.17 (-2.49%)
  • Closed
  • As On: 23 Jun, 2026, 03:31 PM IST
Loading...
Open126.10
High130.00
Low122.05
Prev Close127.37
Volume12,103
VWAP(₹)126.64

Key Metrics

PE Ratio(x)3,212.83
EPS - TTM(₹)0.04
MCap(₹ Cr.)260.08
MCap Rank29
PB Ratio(x)4.40
Div Yield(%)-
Face Value(₹)10.00
52W High(₹)147.00
52W Low(₹)69.36
MCap/Sales3.92
Beta(1 Month)2.05
BV/Share(₹)28.92

Lotus Eye Hosp share price insights

  • Undertaking New Debt

    Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)
  • Employee & Interest Expense

    Company has spent 1.6% of its operating revenues towards interest expenses and 22.66% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • Lotus Eye Hosp Share Price Update

    Lotus Eye Hospital and Institute Ltd. share price moved down by -2.49% from its previous close of Rs 127.37. Lotus Eye Hospital and Institute Ltd. stock last traded price is 124.21

    Share PriceValue
    Today/Current/Last124.21
    Previous Day127.37

Found Insights useful?

Lotus Eye Hosp Share Price Returns

1 Day-2.49%
1 Month13.76%
3 Months19.02%
1 Year76.81%
3 Years50.19%
5 Years159.58%

Lotus Eye Hosp Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income14.0913.7913.3113.7012.02
    Total Income Growth (%)2.223.57-2.8813.99-3.57
    Total Expenses14.2413.8713.1112.8611.09
    Total Expenses Growth (%)2.645.821.9815.98-13.17
    EBIT-0.15-0.090.200.850.94
    EBIT Growth (%)--145.33-76.65-9.51-
    Profit after Tax (PAT)-0.32-0.260.120.540.25
    PAT Growth (%)--325.13-78.74115.93-
    EBIT Margin (%)-1.06-0.651.496.187.79
    Net Profit Margin (%)-2.27-1.890.873.982.10
    Basic EPS (₹)-0.15-0.130.060.260.12
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue54.8950.8649.5148.1939.80
    Total Revenue Growth (%)7.922.732.7521.0920.19
    Total Expenses54.9449.4945.5042.5435.69
    Total Expenses Growth (%)11.018.766.9819.1714.40
    Profit after Tax (PAT)0.080.742.914.082.98
    PAT Growth (%)-89.12-74.63-28.5236.6390.33
    Operating Profit Margin (%)1.503.488.5112.2210.87
    Net Profit Margin (%)0.141.496.048.667.67
    Basic EPS (₹)0.040.361.401.961.44

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Employee & Interest Expense

      Company has spent 1.6% of its operating revenues towards interest expenses and 22.66% towards employee cost in the year ending Mar 31, 2026. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets82.6069.5766.6363.1961.60
    Total Assets Growth (%)18.734.415.442.584.00
    Total Liabilities22.469.577.225.616.99
    Total Liabilities Growth (%)134.6932.5528.70-19.747.04
    Total Equity60.1460.0059.4157.5854.61
    Total Equity Growth (%)0.230.993.185.443.62
    Current Ratio (x)1.221.562.252.832.24
    Total Debt to Equity (x)0.190.000.000.000.00
    Contingent Liabilities0.000.820.840.900.90

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Undertaking New Debt

      Company has outstanding debt obligations for the first time in last 5 years. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities3.142.705.684.394.39
    Net Cash used in Investing Activities-12.37-3.99-4.63-2.19-3.92
    Net Cash flow from Financing Activities9.03-1.60-3.40-1.71-1.58
    Net Cash Flow-0.20-2.89-2.350.49-1.10
    Closing Cash & Cash Equivalent1.812.016.939.288.79
    Closing Cash & Cash Equivalent Growth (%)-10.08-70.98-25.335.54-11.11
    Total Debt/ CFO (x)3.640.000.000.000.00

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Increase in Cash from Investing

      Company has used Rs 12.37 cr for investing activities which is an YoY increase of 209.78%. (Source: Standalone Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)0.131.234.907.085.46
    Return on Capital Employed (%)1.102.786.799.917.57
    Return on Assets (%)0.091.064.376.454.84
    Interest Coverage Ratio (x)5.3113.3480.4289.4752.56
    Asset Turnover Ratio (x)0.710.730.740.750.64
    Price to Earnings (x)3,333.33200.0040.4929.6737.31
    Price to Book (x)3.502.421.982.102.03
    EV/EBITDA (x)47.9029.8314.1012.8715.17
    EBITDA Margin (%)8.489.5516.2418.5617.30

    No Data Available

Found Financials useful?

Technicals

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters83,47,10240.14 %-0.53
    Pledge72,74,27287.15 %87.15
    FII2940.00 %-0.01
    Others1,24,48,93459.86 %0.53
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters40.1440.6740.6440.39
    Pledge87.150.000.000.00
    FII0.000.010.000.01
    DII0.000.000.000.00
    Mutual Funds0.000.000.000.00
    Others59.8659.3259.3659.60

Mutual Funds Ownership

No Data Available

Corporate Actions

  • Board Meeting

    Audited Results

    May 21, 2026

    Board Meeting

    Others

    Mar 12, 2026

    Board Meeting

    Quarterly Results

    Jan 30, 2026

  • Announced onMeeting on
    May 21, 2026May 26, 2026
    Audited Results
    Mar 12, 2026Mar 17, 2026
    Others
    Jan 30, 2026Feb 11, 2026
    Quarterly Results
    Oct 31, 2025Nov 12, 2025
    Quarterly Results
    Aug 04, 2025Aug 12, 2025
    Quarterly Results
  • Announced onEx-DateDividend%
    May 25, 2023Sep 18, 20235%
    May 25, 2022Sep 08, 20225%
    Jun 30, 2021Sep 08, 20215%
    May 29, 2018Sep 14, 20185%
    Jul 17, 2017Aug 02, 20175%
  • No Data Available

  • No Data Available

  • No Data Available

  • Announced onMeeting on
    Dec 18, 2025Jan 20, 2026
    -
    Sep 08, 2025Sep 23, 2025
    Book closure from Sep 17, 2025 to Sep 23, 2025
    May 27, 2024Aug 13, 2024
    Book closure from Aug 7, 2024 to Aug 13, 2024
    Sep 01, 2023Sep 25, 2023
    Rs.0.5000 per share(5%)Final Dividend & A.G.M.
    Feb 16, 2023Mar 21, 2023
    -

About Lotus Eye Hosp

Lotus Eye Hospital and Institute Ltd., incorporated in the year 1997, is a Small Cap company (having a market cap of Rs 264.88 Crore) operating in Hospitals & Allied Services sector.

Show More

Industry

Hospital

Key Indices Listed On

-

Address

S.F No.770/12,Avinashi Road,Coimbatore, Tamil Nadu - 641014

Executive Leadership

KS

Kavetha Sundaramoorthy

Chairman
SS

Sangeetha Sundaramoorthy

Managing Director
KS

K S Ramalingam

WholeTime Director & CEO
KV

Karthik Veeramani

Director
Show More

Auditors

Anbarasu & Jalapathi

FAQs about Lotus Eye Hosp share

  • 1. What is Lotus Eye Hosp share price and what are the returns for Lotus Eye Hosp share?
    As on 23 Jun, 2026, 03:31 PM IST Lotus Eye Hosp share price is down by 2.49% basis the previous closing price of Rs 127.69. Lotus Eye Hosp share price is Rs 124.21. Return Performance of Lotus Eye Hosp Shares:
    • 1 Week: Lotus Eye Hosp share price moved down by 11.20%
  • 2. What's the market capitalization of Lotus Eye Hosp?
    Lotus Eye Hosp share has a market capitalization of Rs 260.08 Cr. Within Hospitals & Allied Services sector, it's market cap rank is 29.
  • 3. What has been highest price of Lotus Eye Hosp share in last 52 weeks?
    Lotus Eye Hosp share price saw a 52 week high of Rs 147.00 and 52 week low of Rs 69.36.
  • 4. What are the returns for Lotus Eye Hosp share?
    Return Performance of Lotus Eye Hosp Shares:
    • 1 Week: Lotus Eye Hosp share price moved down by 11.20%
  • 5. What is the PE & PB ratio of Lotus Eye Hosp?
    The PE ratio of Lotus Eye Hosp stands at 3294.56, while the PB ratio is 4.4.

Top Gainers

As on 03:59 PM | 23 Jun 2026
Suven Pharma
457.80
52.56 (12.97%)
Piramal Pharma
168.89
10.38 (6.55%)
Neuland Labs
18,102.00
878.00 (5.10%)
Gland Pharma
2,298.20
111.50 (5.10%)
BASF India
3,745.80
172.91 (4.84%)

Top Losers

As on 03:59 PM | 23 Jun 2026
New India Assurance
195.10
-17.02 (-8.02%)
Vedanta
281.70
-24.16 (-7.90%)
NALCO
355.40
-22.56 (-5.97%)
Aegis Vopak Terminal
232.76
-13.54 (-5.50%)
Hindustan Zinc
546.80
-26.41 (-4.61%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.